In 2023, the total fertility rate in children per woman in the United Kingdom stood at 1.56. Between 1960 and 2023, the figure dropped by 1.13, though the decline followed an uneven course rather than a steady trajectory.

The United Kingdom: Fertility rate, births per woman: The latest value from 2023 is 1.56 births per woman, unchanged from 1.56 births per woman in 2022. In comparison, the world average is 2.41 births per woman, based on data from 196 countries. Historically, the average for the United Kingdom from 1960 to 2023 is 1.95 births per woman. The minimum value, 1.56 births per woman, was reached in 2022 while the maximum of 2.93 births per woman was recorded in 1964.

Virgin Islands (British) Fertility Rate: Total: Births per Woman data was reported at 1.045 Ratio in 2023. This records an increase from the previous number of 1.025 Ratio for 2022. Virgin Islands (British) Fertility Rate: Total: Births per Woman data is updated yearly, averaging 1.798 Ratio from Dec 1960 (Median) to 2023, with 64 observations. The data reached an all-time high of 4.812 Ratio in 1960 and a record low of 0.873 Ratio in 2017. Virgin Islands (British) Fertility Rate: Total: Births per Woman data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Virgin Islands (British) – Table VG.World Bank.WDI: Social: Health Statistics. Total fertility rate represents the number of children that would be born to a woman if she were to live to the end of her childbearing years and bear children in accordance with age-specific fertility rates of the specified year.;(1) United Nations Population Division. World Population Prospects: 2024 Revision; (2) Statistical databases and publications from national statistical offices; (3) Eurostat: Demographic Statistics.;Weighted average;Relevance to gender indicator: it can indicate the status of women within households and a woman’s decision about the number and spacing of children.

Actual value and historical data chart for United Kingdom Adolescent Fertility Rate Births Per 1 000 Women Ages 15 19

In 2024, Monaco was the European country estimated to have the highest fertility rate. The country had a fertility rate of 2.1 children per woman. Other small countries such as Gibraltar or Montenegro also came towards the top of the list for 2024, while the large country with the highest fertility rate was France, with 1.64 children per woman. On the other hand, Ukraine had the lowest fertility rate, averaging around one child per woman.

Snapshot img

Fertility Services Market Size 2025-2029

The fertility services market size is forecast to increase by USD 9.53 billion, at a CAGR of 7.8% between 2024 and 2029.

The market is a continually evolving landscape, driven by various factors that shape its dynamics. One significant trend is the increasing demand for fertility treatments due to the rising prevalence of late parenthood. According to recent studies, the number of women giving birth over the age of 35 has increased by 23.3% in the last decade. This demographic shift has led to a surge in demand for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Moreover, the market is also influenced by the growing incidence of prostate cancer, which can impact male fertility. According to the American Cancer Society, there will be approximately 193,000 new cases of prostate cancer diagnosed in the US in 2022.
This statistic underscores the importance of fertility services in addressing the reproductive health needs of cancer survivors. Despite these growth opportunities, the market faces challenges, including high complication rates associated with fertility treatments. For instance, the risk of multiple pregnancies and ovarian hyperstimulation syndrome (OHSS) are significant concerns. These complications can lead to increased healthcare costs and potential long-term health risks for patients. The market is a complex and dynamic industry, shaped by demographic trends, health concerns, and technological advancements. As the demand for fertility treatments continues to rise, stakeholders must navigate the challenges and opportunities that come with this evolving landscape.

Major Market Trends & Insights

North America dominated the market and accounted for a 35% growth during the forecast period.
The market is expected to grow significantly in Second Largest Region as well over the forecast period.
By the Service, the Treatment services sub-segment was valued at USD 6.65 billion in 2023
By the End-user, the Fertility clinics sub-segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 89.23 billion
Future Opportunities: USD USD 9.53 billion 
CAGR : 7.8%
North America: Largest market in 2023

What will be the Size of the Fertility Services Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

Fertility services encompass a range of medical interventions and technologies designed to help individuals and couples achieve pregnancy. One significant area within this market is the use of fertility medications, which play a crucial role in assisted reproductive technology (ART). According to recent reports, approximately 12% of women in the United States have used some form of fertility medication. ART involves various techniques, including artificial insemination, ovulation predictor kits, and ovarian stimulation protocols, among others. Cervical mucus plays a vital role in the natural process of conception, but ART may bypass this step through the use of intrauterine insemination (IUI) or in vitro fertilization (IVF).
In IUI, semen cryopreservation is essential for the success of the procedure. Ovarian stimulation protocols, such as ovulation induction, are commonly used in ART to increase the number of mature follicles and improve the chances of successful pregnancy. Ovulation predictor kits help individuals monitor their menstrual cycle and identify the most fertile days for conception. Despite the advancements in fertility services, challenges persist. Miscarriage rates remain a concern, with approximately 10-20% of known pregnancies ending in miscarriage. Blastocyst development is a critical factor in the success of ART, with implantation rate and pregnancy rate being essential indicators of treatment efficacy.
Reproductive endocrinology, a subspecialty of obstetrics and gynecology, focuses on the diagnosis and treatment of infertility. Donor insemination and ectopic pregnancy are other areas of fertility services that have gained increasing attention. Embryo culture media and ultrasound imaging are essential tools used in the field to monitor the development of embryos and assess the progress of pregnancies. Looking ahead, the market is expected to grow substantially. According to market reports, the global ART market is projected to expand at a significant rate, with an increase of around 15% in the number of ART cycles performed annually.
This growth is driven by factors such as rising infertility rates, increasing awareness, and advancements in technology. Comparing the growth rates of different regions, Asia Pacific is expected to witness the fastest growth in the ART market due to factors such as increasing disposable income, changing social norms, and government initiatives to promote fertility treatments

Introduction to fertility estimates

Fertility refers to the number of live births within an individual or group, influenced by a combination of biological, social, cultural, and economic factors.

There are several ways to describe fertility rates, but two of the most commonly used are Age-Specific Fertility Rates (ASFR) and Total Fertility Rates (TFR).

Age-specific fertility rates (ASFR) measure the number of births per woman within specific age groups. For example, in England, the peak childbearing age is currently 32, with an ASFR of 0.107, meaning 107 babies were born for each 1,000 women aged 32.

Total fertility rate (TFR) is a commonly used measure of overall fertility calculated as the sum of all age-specific fertility rates across all reproductive age groups. It represents the average number of children that a woman would have if she were to experience current age-specific fertility rates over the course of her life. For 2023, we estimate the TFR in Inner London to have been 1.16 compared to 1.54 in Outer London, and 1.41 for England as whole.

About these estimates

The estimates published here were produced by the GLA for use in analysis and as inputs to population projections. These data include annual estimates for all local authority districts and regions in England and Wales from 1993 onward of:

• Total Fertility Rates
• Age-Specific Fertility Rates by single year of age (15 to 49)

The GLA is making these estimates and the code used to create them as a resource for analysts and researchers working to understand local birth trends. We welcome feedback and suggestions from the community for how these data could be improved or made more useful.

The code used to produce these estimates is available on GitHub. All the requirements and information necessary to recreate the estimates can be found in the README file. This repository also includes some examples of code for plotting age-specific and total fertility rates across local authorities and periods of interest.

The Office for National Statistics also publishes fertility rates for local authority districts and higher geographies. Age-specific fertility rates are published by five-year age groups and for 2013 onward. These data are available to download from Nomis.

Note: There will be differences between the rates published by the GLA and those available from ONS. These are because the GLA:

• models rates for individual ages 15 to 19 and 40 to 49 from aggregate data
• applies smoothing to age specific rates
• uses population denominators for 2002 to 2020 that differ from the official mid-year estimates used by ONS.

Data and methods

The data used to calculate fertility rate estimates are:

• ONS calendar year births by age of mother from 1993
• ONS mid-year population estimates from 1991 - 2000
• GLA estimates components of change modelled backseries from 2000

Raw age-specific fertility rates are calculated by dividing the number of births in a calendar year by the population of women the same age at the mid-point of that year.

Smoothed rates, covering individual ages from 15 to 49 are produced by fitting a series of parametric curves to the raw fertility rates.

Age-specific fertility rates are summed across all ages to obtain total fertility rates.

https://cdn.datapress.cloud/london/img/dataset/55c81b8d-b5fb-40d6-9ca5-16946d2aa2c7/2025-10-07T14%3A01%3A14/bf7f1c64673b9fa8ae0b71c9b6d24e4c.webp" alt="Embedded Image" />

https://cdn.datapress.cloud/london/img/dataset/55c81b8d-b5fb-40d6-9ca5-16946d2aa2c7/2025-10-07T14%3A01%3A15/6388a88f4fe9468674b38446216a71a9.webp" alt="Embedded Image" />

Actual value and historical data chart for United Kingdom Fertility Rate Total Births Per Woman

This is a publication on maternity activity in English NHS hospitals. This report examines data relating to delivery and birth episodes in 2023-24, and the booking appointments for these deliveries. This annual publication covers the financial year ending March 2024. Data is included from both the Hospital Episodes Statistics (HES) data warehouse and the Maternity Services Data Set (MSDS). HES contains records of all admissions, appointments and attendances for patients admitted to NHS hospitals in England. The HES data used in this publication are called 'delivery episodes'. The MSDS collects records of each stage of the maternity service care pathway in NHS-funded maternity services, and includes information not recorded in HES. The MSDS is a maturing, national-level dataset. In April 2019, the MSDS transitioned to a new version of the dataset. This version, MSDS v2.0, is an update that introduced a new structure and content - including clinical terminology, in order to meet current clinical practice and incorporate new requirements. It is designed to meet requirements that resulted from the National Maternity Review, which led to the publication of the Better Births report in February 2016. This is the fifth publication of data from MSDS v2.0 and data from 2019-20 onwards is not directly comparable to data from previous years. This publication shows the number of HES delivery episodes during the period, with a number of breakdowns including by method of onset of labour, delivery method and place of delivery. It also shows the number of MSDS deliveries recorded during the period, with a breakdown for the mother's smoking status at the booking appointment by age group. It also provides counts of live born term babies with breakdowns for the general condition of newborns (via Apgar scores), skin-to-skin contact and baby's first feed type - all immediately after birth. There is also data available in a separate file on breastfeeding at 6 to 8 weeks. For the first time information on 'Smoking at Time of Delivery' has been presented using annual data from the MSDS. This includes national data broken down by maternal age, ethnicity and deprivation. From 2025/2026, MSDS will become the official source of 'Smoking at Time of Delivery' information and will replace the historic 'Smoking at Time of Delivery' data which is to become retired. We are currently undergoing dual collection and reporting on a quarterly basis for 2024/25 to help users compare information from the two sources. We are working with data submitters to help reconcile any discrepancies at a local level before any close down activities begin. A link to the dual reporting in the SATOD publication series can be found in the links below. Information on how all measures are constructed can be found in the HES Metadata and MSDS Metadata files provided below. In this publication we have also included an interactive Power BI dashboard to enable users to explore key NHS Maternity Statistics measures. The purpose of this publication is to inform and support strategic and policy-led processes for the benefit of patient care. This report will also be of interest to researchers, journalists and members of the public interested in NHS hospital activity in England. Any feedback on this publication or dashboard can be provided to enquiries@nhsdigital.nhs.uk, under the subject “NHS Maternity Statistics”.

Time series data for the statistic Fertility_Rate and country United Kingdom. Indicator Definition:Total fertility rate represents the number of children that would be born to a woman if she were to live to the end of her childbearing years and bear children in accordance with age-specific fertility rates of the specified year.The statistic "Fertility Rate" stands at 1.56 births per woman as of 12/31/2023. Regarding the One-Year-Change of the series, the current value is equal to the value the year prior.The 1 year change in percent is 0.0.The 3 year change in percent is -0.7002.The 5 year change in percent is -7.14.The 10 year change in percent is -14.75.The Serie's long term average value is 1.95 births per woman. It's latest available value, on 12/31/2023, is 20.03 percent lower, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 12/31/2023, is +0.0%.The Serie's change in percent from it's maximum value, on 12/31/1964, to it's latest available value, on 12/31/2023, is -46.76%.

This is a publication on maternity activity in English NHS hospitals. This report examines data relating to delivery and birth episodes in 2022-23, and the booking appointments for these deliveries. This annual publication covers the financial year ending March 2023. Data is included from both the Hospital Episodes Statistics (HES) data warehouse and the Maternity Services Data Set (MSDS). HES contains records of all admissions, appointments and attendances for patients admitted to NHS hospitals in England. The HES data used in this publication are called 'delivery episodes'. The MSDS collects records of each stage of the maternity service care pathway in NHS-funded maternity services, and includes information not recorded in HES. The MSDS is a maturing, national-level dataset. In April 2019 the MSDS transitioned to a new version of the dataset. This version, MSDS v2.0, is an update that introduced a new structure and content - including clinical terminology, in order to meet current clinical practice and incorporate new requirements. It is designed to meet requirements that resulted from the National Maternity Review, which led to the publication of the Better Births report in February 2016. This is the fourth publication of data from MSDS v2.0 and data from 2019-20 onwards is not directly comparable to data from previous years. This publication shows the number of HES delivery episodes during the period, with a number of breakdowns including by method of onset of labour, delivery method and place of delivery. It also shows the number of MSDS deliveries recorded during the period, with breakdowns including the baby's first feed type, birthweight, place of birth, and breastfeeding activity; and the mothers' ethnicity and age at booking. There is also data available in a separate file on breastfeeding at 6 to 8 weeks. The count of Total Babies includes both live and still births, and previous changes to how Total Babies and Total Deliveries were calculated means that comparisons between 2019-20 MSDS data and later years should be made with care. Information on how all measures are constructed can be found in the HES Metadata and MSDS Metadata files provided below. In this publication we have also included an interactive Power BI dashboard to enable users to explore key NHS Maternity Statistics measures. The purpose of this publication is to inform and support strategic and policy-led processes for the benefit of patient care. This report will also be of interest to researchers, journalists and members of the public interested in NHS hospital activity in England. Any feedback on this publication or dashboard can be provided to enquiries@nhsdigital.nhs.uk, under the subject “NHS Maternity Statistics”.

Actual value and historical data chart for British Virgin Islands Fertility Rate Total Births Per Woman

Actual value and historical data chart for British Virgin Islands Adolescent Fertility Rate Births Per 1000 Women Ages 15 19

Snapshot img

Fertility Supplements Market Size 2025-2029

The fertility supplements market size is forecast to increase by USD 843.8 million, at a CAGR of 7.3% between 2024 and 2029. Availability of online purchase will drive the fertility supplements market.

Major Market Trends & Insights

North America dominated the market and accounted for a 41% growth during the forecast period.
By End-user - Women segment was valued at USD 910.80 million in 2023
By Form Factor - Capsules segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 70.99 million
Market Future Opportunities: USD 843.80 million 
CAGR : 7.3%
North America: Largest market in 2023

Market Summary

The market represents a significant and continually evolving sector within the health and wellness industry. Core technologies and applications, such as herbal extracts, vitamins, and minerals, play a crucial role in the development and production of these supplements. The market is segmented into various product categories, including prenatal vitamins, men's fertility supplements, and herbal supplements. Key companies, including Herbalife Nutrition, Nutraceutical Corporation, and Swanson Health Products, dominate the market with their extensive product offerings and strong market presence. The market's growth is driven by factors such as increasing cases of infertility, an aging population seeking to maintain reproductive health, and the availability of online purchasing options. However, challenges such as the risk associated with unregulated supplements and potential side effects pose significant hurdles for market growth. Regulations, particularly from the Food and Drug Administration (FDA), play a critical role in ensuring the safety and efficacy of fertility supplements. According to recent studies, The market is expected to witness a steady growth trajectory in the forecast period, with a significant increase in adoption rates. For instance, the prenatal vitamins segment is projected to account for over 50% of the market share due to their importance in supporting maternal health and fetal development. Related markets such as the dietary supplements and pharmaceuticals industries also significantly influence the market. Stay tuned for more insights and updates on this dynamic market.

What will be the Size of the Fertility Supplements Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Fertility Supplements Market Segmented and what are the key trends of market segmentation?

The fertility supplements industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. End-userWomenMenForm FactorCapsulesTabletsGummiesPowdersOthersProduct TypeHerbal supplementsVitamin-basedMineral-basedAmino acids and antioxidantsProbioticsGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalySpainUKAPACChinaIndiaJapanRest of World (ROW)

By End-user Insights

The women segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth, driven by the increasing prevalence of infertility issues and the expanding demand for natural and sustainable solutions. Approximately 17.5% of individuals of reproductive age worldwide have experienced infertility at some point in their lives, according to the World Health Organization's 2023 report. Disorders such as polycystic ovarian syndrome (PCOS), endometriosis, premature ovarian failure, and pelvic inflammatory disease are just a few of the systemic and gynecological conditions that can negatively impact the female reproductive system. To address these challenges, the market for fertility supplements is evolving rapidly. Nitrogen fixation bacteria and root growth stimulants are increasingly being used to improve soil health and nutrient availability, enhancing crop stress tolerance and promoting sustainable agriculture. Microbial inoculants and plant hormone modulators are also gaining popularity for their role in nutrient deficiency diagnosis and soil testing methods, as well as for drought stress mitigation and water use efficiency. Moreover, fertilizer blend formulations, humic acid fertilizers, and foliar fertilizer applications are being employed to optimize nutrient uptake efficiency and improve fruit quality. Precision fertilization and grain quality enhancement are also key trends, as growers seek to minimize waste and maximize yields. Phosphorus solubilizing fungi, plant growth regulators, and soil nutrient cycling are also essential components of this evolving market. Looking ahead, industry experts anticipate continued growth, with expectations of a 21.3% increase in market siz

There were almost 695,000 live births recorded in the United Kingdom in 2021, compared with almost 682,000 in the previous year. Between 1887 and 2021, the year with the highest number of live births was 1920, when there were approximately 1.13 million births, while the year with the fewest births was 1977, when there were approximately 657,000 births. Birth rate falls to a historic low in 2020 At 10.2 births per 1,000 people, the birth rate of the United Kingdom in 2020 was at a historic low. After witnessing a twenty-first century high of 12.9 in 2010, the birth rate gradually declined before a sharp decrease was recorded between 2012 and 2013. Although there was a slight uptick in the birth rate in 2021, when there were 10.4 births per 1,000 people, the total fertility rate reached a low of 1.53 births per woman in the same year. As well as falling birth and fertility rates, the average age of mothers has been increasing. In 1991, the average age of mothers at childbirth was 27.7 years, compared with 30.9 years in 2021. UK population reaches 68 million In 2023, the overall population of the United Kingdom reached almost 68.3 million people. Of the four countries that comprise the UK, England has by far the highest population, at 57.7 million, compared with almost 5.5 million in Scotland, 3.2 million in Wales, and 1.9 million in Northern Ireland. These countries are far less densely populated than England, especially when compared to London, which had approximately 5,630 people per square kilometer, compared with just 70 in Scotland. After London, North West England was the second-most densely populated area of the UK, which includes the large metropolitan areas of the cities of Manchester, and Liverpool